Chronic obstructive pulmonary disease (COPD) is a progressive but potentially treatable and preventable disease characterized by chronic airflow limitation and associated with an abnormal inflammatory response of the lungs to noxious particles or gases.
1 Current surveillance data show that more than 13.5 million adults 25 years and older in the United States have COPD.
2 Chronic airflow limitation can result in hypoxemia and hypercapnia, which may predispose these patients to an increased risk for cognitive dysfunction.
3,4